Imagine if doctors could determine, many years in advance, who is likely to develop dementia. Such prognostic capabilities would give patients and their families time to plan and manage treatment and care. Thanks to artificial intelligence research conducted at McGill University, this kind of predictive power could soon be available to clinicians everywhere.
Scientists from the Douglas Mental Health University Institute’s Translational Neuroimaging Laboratory at McGill used artificial intelligence techniques and big data to develop an algorithm capable of recognizing the signatures of dementia two years before its onset, using a single amyloid PET scan of the brain of patients at risk of developing Alzheimer’s disease. Their findings appear in a new study published in the journal Neurobiology of Aging.
Dr. Pedro Rosa-Neto, co-lead author of the study and Associate Professor in McGill’s departments of Neurology & Neurosurgery and Psychiatry, expects that this technology will change the way physicians manage patients and greatly accelerate treatment research into Alzheimer’s disease.
“By using this tool, clinical trials could focus only on individuals with a higher likelihood of progressing to dementia within the time frame of the study. This will greatly reduce the cost and the time necessary to conduct these studies,” adds Dr. Serge Gauthier, co-lead author and Professor of Neurology & Neurosurgery and Psychiatry at McGill.
Amyloid as a biomarker of dementia
Scientists have long known that a protein known as amyloid accumulates in the brain of patients with mild cognitive impairment (MCI), a condition that often leads to dementia. Though the accumulation of amyloid begins decades before the symptoms of dementia occur, this protein couldn’t be used reliably as a predictive biomarker because not all MCI patients develop Alzheimer’s disease.
To conduct their study, the McGill researchers drew on data available through the Alzheimer’s Disease Neuroimaging Initiative (ADNI), a global research effort in which participating patients agree to complete a variety of imaging and clinical assessments.
Sulantha Mathotaarachchi, a computer scientist from Rosa-Neto’s and Gauthier’s team, used hundreds of amyloid PET scans of MCI patients from the ADNI database to train the team’s algorithm to identify which patients would develop dementia, with an accuracy of 84%, before symptom onset. Research is ongoing to find other biomarkers for dementia that could be incorporated into the algorithm in order to improve the software’s prediction capabilities.
“This is an example how big data and open science brings tangible benefits to patient care,” says Dr. Rosa-Neto, who is also director of the McGill University Research Centre for Studies in Aging.
While new software has been made available online to scientists and students, physicians won’t be able to use this tool in clinical practice before certification by health authorities. To that end, the McGill team is currently conducting further testing to validate the algorithm in different patient cohorts, particularly those with concurrent conditions such as small strokes.
The Latest on: Predictive medicine using artificial intelligence
- The Impact Of Artificial Intelligence Is Already Here, It's Just Not Very Evenly Distributed on September 29, 2018 at 9:53 am
With apologies to author William Gibson, who originally pointed out that "the future is already here, it's just not very distributed," we can say that the impact of artificial intelligence ... develop... […]
- The Spooky Genius of Artificial Intelligence on September 28, 2018 at 7:22 am
Can artificial ... use this painfully dense genie. “Everywhere!” he said. Most importantly, generative design could help biologists simulate the effect of new drugs without putting sick humans at risk ... […]
- Global Artificial Intelligence in IoT Markets 2018-2023 - Global AI Chipsets market will reach $6.6 Billion on September 28, 2018 at 3:36 am
3.3 AI Driven Networking Solution Market by AI Technology Type 3.4 AI Driven Networking Solution Market by Deployment Type 3.5 AI Driven Networking Solution Market by Industry Sector 3.6 AI Driven ... […]
- Medicrea Hosts First-Ever Spine Artificial Intelligence Focused Meeting in Lyon, France on September 26, 2018 at 4:21 pm
The Medicrea ® Group (Euronext Growth Paris: FR0004178572 - ALMED), pioneering the transformation of spinal surgeries through Artificial Intelligence ... the lens of predictive medicine, Medicrea ... […]
- Medicrea Announces NASS 2018 Presence And Highlights a Recently Published Study Validating Its Predictive Modelling Approach for AIS Patients on September 26, 2018 at 2:36 pm
The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED, PEA-PME eligible, and OTCQX: MNRTY and MNRTF), pioneering the transformation of spinal surgeries through Artificial Intelligence ... Th... […]
- Higher education embraces artificial intelligence and predictive analytics with SAS® Viya® on September 25, 2018 at 5:45 am
SAS Viya puts the latest in machine learning, artificial intelligence, forecasting and text analytics ... view of a student to bolster freshman performance. OSU also plans to use SAS predictive analyt... […]
- Artificial intelligence in medicine marketscrutinized in new research on September 25, 2018 at 4:16 am
The Global Artificial Intelligence in Medicine Market Report includes a comprehensive analysis ... We make sense of drawbacks, opportunities, circumstances, estimations, and information using our expe... […]
- Artificial intelligence to improve drug combination design and personalized medicine on September 24, 2018 at 11:27 pm
A new auto-commentary published in SLAS Technology looks at how an emerging area of artificial intelligence ... using a quadratic phenotypic optimization platform (QPOP), Science Translational ... […]
- Telemedicine meets artificial intelligence at bedside on September 12, 2018 at 7:13 am
One of the most serious problems in taking care of the elderly, disabled or those with a chronic disease is getting them to take their medicine or participate ... that meld telemedicine with artificia... […]
- Predicting the response to immunotherapy using artificial intelligence on August 27, 2018 at 8:56 am
A study published in The Lancet Oncology establishes for the first time that artificial intelligence ... medicine) have created a so-called radiomic signature. This signature defines the level of lymp... […]
via Google News and Bing News